Rapid Micro Biosystems, Inc. (RPID) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated May 4, 2023, details the results of the Company's Annual Meeting of Stockholders held on that date. The filing reports on the election of directors and the ratification of the independent registered public accounting firm.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters and does not contain financial performance data.
Material Changes and Voting Results
Two primary matters were voted upon by stockholders:
- Director Elections: Stockholders elected Jeffrey Schwartz, Richard Kollender, and Natale Ricciardi as Class II Directors. Their terms will serve until the 2026 Annual Meeting.
- Jeffrey Schwartz: 26,007,817 votes For; 1,756,781 votes Withheld.
- Richard Kollender: 23,893,108 votes For; 3,871,490 votes Withheld.
- Natale Ricciardi: 25,721,530 votes For; 2,043,068 votes Withheld.
- Accounting Firm Ratification: Stockholders ratified the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2023.
- Results: 34,810,913 votes For; 24,946 votes Against; 619 votes Abstaining.
Voting Participation: Of 36,635,108 shares eligible to vote, 34,836,478 shares were present in person or by proxy.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Verify the tenure of the newly elected Class II Directors (Schwartz, Kollender, Ricciardi) through the 2026 Annual Meeting.
- Confirm the appointment of PricewaterhouseCoopers LLP as the auditor for the fiscal year ending December 31, 2023.
- Note that this 8-K filing contains no financial performance data; refer to the most recent 10-K or 10-Q for financial metrics.